News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,825 Results
Type
Article (40901)
Company Profile (256)
Press Release (666668)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (206713)
Career Advice (2020)
Deals (35823)
Drug Delivery (95)
Drug Development (81291)
Employer Resources (172)
FDA (16376)
Job Trends (14983)
News (348779)
Policy (32857)
Tag
Academia (2597)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50343)
ALS (88)
Alzheimer's disease (1398)
Antibody-drug conjugate (ADC) (125)
Approvals (16380)
Artificial intelligence (266)
Autoimmune disease (22)
Automation (16)
Bankruptcy (364)
Best Places to Work (11703)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (176)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (280)
Cancer (2270)
Cardiovascular disease (174)
Career advice (1689)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (20)
Clinical research (66146)
Collaboration (836)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2614)
CRISPR (40)
C-suite (245)
Cystic fibrosis (101)
Data (2210)
Decentralized trials (2)
Denatured (18)
Depression (45)
Diabetes (271)
Diagnostics (6758)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (87430)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (113681)
Executive appointments (728)
FDA (17650)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (104)
Generative AI (24)
Gene therapy (303)
GLP-1 (710)
Government (4460)
Grass and pollen (4)
Guidances (67)
Healthcare (19012)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2758)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (314)
IPO (16663)
IRA (41)
Job creations (3691)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (471)
Leadership (17)
Legal (7961)
Liver cancer (77)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (67)
Medical device (13525)
Medtech (13530)
Mergers & acquisitions (19704)
Metabolic disorders (687)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1937)
NextGen: Class of 2025 (6557)
Non-profit (4536)
Now hiring (39)
Obesity (365)
Opinion (205)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (113)
Peanut (47)
People (57972)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20607)
Phase II (29136)
Phase III (21693)
Pipeline (1206)
Policy (140)
Postmarket research (2567)
Preclinical (8770)
Press Release (66)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (253)
Rare diseases (379)
Real estate (6000)
Recruiting (65)
Regulatory (22524)
Reports (46)
Research institute (2361)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (131)
Series B (84)
Service/supplier (12)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3657)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (690)
Venture capitalists (42)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Last 7 days (902)
Last 30 days (2543)
Last 365 days (32858)
2025 (10831)
2024 (35518)
2023 (40432)
2022 (51549)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35405)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38616)
Australia (6333)
California (6174)
Canada (2024)
China (525)
Colorado (267)
Connecticut (277)
Delaware (148)
Europe (83575)
Florida (913)
Georgia (212)
Idaho (57)
Illinois (543)
India (25)
Indiana (310)
Iowa (11)
Japan (163)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (899)
Massachusetts (4590)
Michigan (220)
Minnesota (399)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (66)
New Jersey (1734)
New Mexico (30)
New York (1758)
North Carolina (1006)
North Dakota (8)
Northern California (2688)
Ohio (206)
Oklahoma (14)
Oregon (34)
Pennsylvania (1377)
Puerto Rico (12)
Rhode Island (33)
South America (1114)
South Carolina (23)
South Dakota (1)
Southern California (2327)
Tennessee (101)
Texas (915)
United States (23316)
Utah (183)
Virginia (146)
Washington D.C. (62)
Washington State (564)
West Virginia (3)
Wisconsin (63)
707,825 Results for "cellanyx diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
Press Releases
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
March 13, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
March 4, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Press Releases
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
January 31, 2025
·
2 min read
Press Releases
Bracco Diagnostics Inc. Launches Update to HeartSee™ With New Features and Expanded Access to Cutting-edge Technology for Coronary Artery Disease Diagnosis
March 18, 2025
·
5 min read
Press Releases
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases.
February 25, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
February 21, 2025
·
4 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
1 of 70,783
Next
